CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 40 enrolled
Drug / intervention
OsteoProbe Systemdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04628221
NCT04628221N/ACompleted
CompareCT.gov

A Single-Arm, Open Label Clinical Study to Collect Safety Data on the Osteoprobe System When Used as a Measurement Tool

Active Life Scientific, Inc.·interventional·Posted Nov 13, 2020·Updated Apr 27, 2021

In Brief

A clinical study evaluating OsteoProbe System for Adverse Effects in the Use of the OsteoProbe System. Completed, enrolled 40 participants across 1 site.

Detailed Summary

Prospective, Single Center, Open Label Clinical Study. The purpose of the study is to collect safety data associated with the use of the OsteoProbe System. Study Duration is expected to take approximately 3 months from first subject enrolled to the last follow-up visit.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAdverse Effects in the Use of the OsteoProbe System
CountriesUnited States
CollaboratorsMCRA

Timeline

N/ACompletedFinished
202120222023202420252026
First PostedNov 13, 2020
Enrollment StartJul 31, 2020
Primary CompletionNov 30, 2020
Study CompletionDec 30, 2020
TodayJul 2, 2026
Enrollment to primary: 4 monthsPosted 5.6 years ago

Interventions

OsteoProbe Systemdevice

The OsteoProbe® System ("OsteoProbe") is a bone microindentation measurement tool. The device is a measurement tool that is not intended to make a diagnosis or provide a treatment decision. There are no other available measurement tools for clinical assessment of bone's resistance to microindentation.